Ebrahim S Delpassand
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 (NCT06972628) | Ebrahim S Delpassand | 2025-05-23 |
| 177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms (NCT01237457) | Ebrahim S Delpassand | 2010-10-27 |
Track Ebrahim S Delpassand automatically
Every clearance here is in the API, with alerts when new ones post.